Abstract
Successful infection by enveloped viruses relies on the capacity of these pathogens to release their genome in the cytoplasm. This process involves several successive steps including the recruitment of attachment factors by the viral particle, interaction of viral glycoproteins with specific receptors, and fusion of virus and host membranes. Drugs and inhibitors capable of interrupting the infectious cycle by targeting viral or cellular components involved in the entry process have a considerable interest for the development of antiviral strategies susceptible to block the replication cycle at the earliest time. The development of such molecules is underpinned by the elucidation of the host–virus interplay engaged during these steps and by the characterization of the molecular mechanisms governing viral entry. In this chapter, we focus on the mechanisms used by the chikungunya virus (CHIKV), a medically important mosquito-borne alphavirus propagating in many parts of the world, to penetrate into its target cells. The knowledge accumulated on the nature of receptors and endocytic routes hijacked by this pathogen to infect mammalian and mosquito cells is discussed and we summarize the most recent advances in the development of drugs and antibodies targeting CHIKV replication at the receptor binding, internalization, and fusion steps.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abere B, Wikan N, Ubol S, Auewarakul P, Paemanee A, Kittisenachai S, Roytrakul S, Smith DR (2012) Proteomic analysis of chikungunya virus infected microgial cells. PLoS One 7(4), e34800. doi:10.1371/journal.pone.0034800
Abraham R, Mudaliar P, Padmanabhan A, Sreekumar E (2013) Induction of cytopathogenicity in human glioblastoma cells by chikungunya virus. PLoS One 8(9), e75854. doi:10.1371/journal.pone.0075854
Ahn A, Gibbons DL, Kielian M (2002) The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains. J Virol 76(7):3267–3275
Arias-Goeta C, Mousson L, Rougeon F, Failloux AB (2013) Dissemination and transmission of the E1-226V variant of chikungunya virus in Aedes albopictus are controlled at the midgut barrier level. PLoS One 8(2), e57548. doi:10.1371/journal.pone.0057548
Barton DJ, Sawicki SG, Sawicki DL (1991) Solubilization and immunoprecipitation of alphavirus replication complexes. J Virol 65(3):1496–1506
Bernard KA, Klimstra WB, Johnston RE (2000) Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 276(1):93–103. doi:10.1006/viro.2000.0546
Bernard E, Solignat M, Gay B, Chazal N, Higgs S, Devaux C, Briant L (2010) Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One 5(7), e11479. doi:10.1371/journal.pone.0011479
Bernard E, Hamel R, Neyret A, Ekchariyawat P, Moles JP, Simmons G, Chazal N, Despres P, Misse D, Briant L (2014) Human keratinocytes restrict chikungunya virus replication at a post-fusion step. Virology 476C:1–10. doi:10.1016/j.virol.2014.11.013
Blaising J, Levy PL, Polyak SJ, Stanifer M, Boulant S, Pecheur EI (2013) Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking. Antivir Res 100(1):215–219. doi:10.1016/j.antiviral.2013.08.008
Boriskin YS, Pecheur EI, Polyak SJ (2006) Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection. Virol J 3:56. doi:10.1186/1743-422X-3-56
Brighton SW (1984) Chloroquine phosphate treatment of chronic chikungunya arthritis. An open pilot study. S Afr Med J 66(6):217–218
Bron R, Wahlberg JM, Garoff H, Wilschut J (1993) Membrane fusion of Semliki Forest virus in a model system: correlation between fusion kinetics and structural changes in the envelope glycoprotein. EMBO J 12(2):693–701
Byrnes AP, Griffin DE (1998) Binding of Sindbis virus to cell surface heparan sulfate. J Virol 72(9):7349–7356
Cao S, Zhang W (2013) Characterization of an early-stage fusion intermediate of Sindbis virus using cryoelectron microscopy. Proc Natl Acad Sci U S A 110(33):13362–13367. doi:10.1073/pnas.1301911110
Cassell S, Edwards J, Brown DT (1984) Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus. J Virol 52(3):857–864
Chopra A, Saluja M, Venugopalan A (2014) Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol 66(2):319–326. doi:10.1002/art.38221
Collinet C, Stoter M, Bradshaw CR, Samusik N, Rink JC, Kenski D, Habermann B, Buchholz F, Henschel R, Mueller MS, Nagel WE, Fava E, Kalaidzidis Y, Zerial M (2010) Systems survey of endocytosis by multiparametric image analysis. Nature 464(7286):243–249. doi:10.1038/nature08779
Coombs K, Mann E, Edwards J, Brown DT (1981) Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus. J Virol 37(3):1060–1065
Corver J, Bron R, Snippe H, Kraaijeveld C, Wilschut J (1997) Membrane fusion activity of Semliki Forest virus in a liposomal model system: specific inhibition by Zn2+ ions. Virology 238(1):14–21. doi:10.1006/viro.1997.8799
Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Despres P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M (2008) A mouse model for chikungunya: young age and inefficient type-i interferon signaling are risk factors for severe disease. PLoS Pathog 4(2), e29
Davis JL, Hodge HM, Campbell WE Jr (1971) Growth of chikungunya virus in baby hamster kidney cell (BHK-21-clone 13) suspension cultures. Appl Microbiol 21(2):338–341
De Lamballerie X, Boisson V, Reynier JC, Enault S, Charrel RN, Flahault A, Roques P, Le Grand R (2008) On chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis 8(6):837–839. doi:10.1089/vbz.2008.0049
Delogu I, Pastorino B, Baronti C, Nougairede A, Bonnet E, de Lamballerie X (2011) In vitro antiviral activity of arbidol against chikungunya virus and characteristics of a selected resistant mutant. Antivir Res 90(3):99–107. doi:10.1016/j.antiviral.2011.03.182
DeTulleo L, Kirchhausen T (1998) The clathrin endocytic pathway in viral infection. EMBO J 17(16):4585–4593. doi:10.1093/emboj/17.16.4585
Dhanwani R, Khan M, Alam SI, Rao PV, Parida M (2011) Differential proteome analysis of chikungunya virus-infected new-born mice tissues reveal implication of stress, inflammatory and apoptotic pathways in disease pathogenesis. Proteomics 11(10):1936–1951. doi:10.1002/pmic.201000500
Dhanwani R, Khan M, Bhaskar AS, Singh R, Patro IK, Rao PV, Parida MM (2012) Characterization of chikungunya virus infection in human neuroblastoma SH-SY5Y cells: role of apoptosis in neuronal cell death. Virus Res 163(2):563–572. doi:10.1016/j.virusres.2011.12.009
Di Mola A, Peduto A, La Gatta A, Delang L, Pastorino B, Neyts J, Leyssen P, de Rosa M, Filosa R (2014) Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication. Bioorg Med Chem 22(21):6014–6025. doi:10.1016/j.bmc.2014.09.013
Dubrulle M, Mousson L, Moutailler S, Vazeille M, Failloux AB (2009) Chikungunya virus and Aedes mosquitoes: saliva is infectious as soon as two days after oral infection. PLoS One 4(6), e5895. doi:10.1371/journal.pone.0005895
Edwards J, Brown DT (1991) Sindbis virus infection of a Chinese hamster ovary cell mutant defective in the acidification of endosomes. Virology 182(1):28–33
Fongsaran C, Jirakanwisal K, Kuadkitkan A, Wikan N, Wintachai P, Thepparit C, Ubol S, Phaonakrop N, Roytrakul S, Smith DR (2014) Involvement of ATP synthase beta subunit in chikungunya virus entry into insect cells. Arch Virol 159(12):3353–3364. doi:10.1007/s00705-014-2210-4
Gardner CL, Ebel GD, Ryman KD, Klimstra WB (2011) Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence. Proc Natl Acad Sci U S A 108(38):16026–16031. doi:10.1073/pnas.1110617108
Gay B, Bernard E, Solignat M, Chazal N, Devaux C, Briant L (2012) pH-dependent entry of chikungunya virus into Aedes albopictus cells. Infect Genet Evol 12(6):1275–1281. doi:10.1016/j.meegid.2012.02.003
Glasgow LA (1966) Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals. J Bacteriol 91(6):2185–2191
Glomb-Reinmund S, Kielian M (1998) The role of low pH and disulfide shuffling in the entry and fusion of Semliki Forest virus and Sindbis virus. Virology 248(2):372–381. doi:10.1006/viro.1998.9275
Goh LY, Hobson-Peters J, Prow NA, Gardner J, Bielefeldt-Ohmann H, Pyke AT, Suhrbier A, Hall RA (2013) Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model. Clin Immunol 149(3):487–497. doi:10.1016/j.clim.2013.10.004
Heil ML, Albee A, Strauss JH, Kuhn RJ (2001) An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety. J Virol 75(14):6303–6309. doi:10.1128/JVI.75.14.6303-6309.2001
Helenius A, Kartenbeck J, Simons K, Fries E (1980) On the entry of Semliki Forest virus into BHK-21 cells. J Cell Biol 84(2):404–420
Helenius A, Marsh M, White J (1982) Inhibition of Semliki Forest virus penetration by lysosomotropic weak bases. J Gen Virol 58(Pt 1):47–61
Henrik Gad H, Paulous S, Belarbi E, Diancourt L, Drosten C, Kummerer BM, Plate AE, Caro V, Despres P (2012) The E2-E166K substitution restores chikungunya virus growth in OAS3 expressing cells by acting on viral entry. Virology 434(1):27–37. doi:10.1016/j.virol.2012.07.019
Her Z, Malleret B, Chan M, Ong EK, Wong SC, Kwek DJ, Tolou H, Lin RT, Tambyah PA, Renia L, Ng LF (2010) Active infection of human blood monocytes by chikungunya virus triggers an innate immune response. J Immunol 184(10):5903–5913. doi:10.4049/jimmunol.0904181
Higashi N, Matsumoto A, Tabata K, Nagatomo Y (1967) Electron microscope study of development of chikungunya virus in green monkey kidney stable (VERO) cells. Virology 33(1):55–69
Hu D, Zhang J, Wang H, Liu S, Yu L, Sun L, Qu Y (2014) Chikungunya virus glycoproteins pseudotype with lentiviral vectors and reveal a broad spectrum of cellular tropism. PLoS One 9(10), e110893. doi:10.1371/journal.pone.0110893
Huang HC, Tao MH, Hung TM, Chen JC, Lin ZJ, Huang C (2014) (−)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. Antivir Res 111:100–111. doi:10.1016/j.antiviral.2014.09.009
Hunt SR, Hernandez R, Brown DT (2011) Role of the vacuolar-ATPase in Sindbis virus infection. J Virol 85(3):1257–1266. doi:10.1128/JVI.01864-10
Inglot AD (1969) Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs. J Gen Virol 4(2):203–214
Irurzun A, Nieva JL, Carrasco L (1997) Entry of Semliki Forest virus into cells: effects of concanamycin A and nigericin on viral membrane fusion and infection. Virology 227(2):488–492. doi:10.1006/viro.1996.8340
Jemielity S, Wang JJ, Chan YK, Ahmed AA, Li W, Monahan S, Bu X, Farzan M, Freeman GJ, Umetsu DT, Dekruyff RH, Choe H (2013) TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog 9(3), e1003232. doi:10.1371/journal.ppat.1003232
Justman J, Klimjack MR, Kielian M (1993) Role of spike protein conformational changes in fusion of Semliki Forest virus. J Virol 67(12):7597–7607
Kaur P, Thiruchelvan M, Lee RC, Chen H, Chen KC, Ng ML, Chu JJ (2013) Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother 57(1):155–167. doi:10.1128/AAC.01467-12
Khan M, Santhosh SR, Tiwari M, Lakshmana Rao PV, Parida M (2010) Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in vero cells. J Med Virol 82(5):817–824. doi:10.1002/jmv.21663
Klimjack MR, Jeffrey S, Kielian M (1994) Membrane and protein interactions of a soluble form of the Semliki Forest virus fusion protein. J Virol 68(11):6940–6946
Klimstra WB, Ryman KD, Johnston RE (1998) Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol 72(9):7357–7366
Klimstra WB, Nangle EM, Smith MS, Yurochko AD, Ryman KD (2003) DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol 77(22):12022–12032
Kononchik JP Jr, Hernandez R, Brown DT (2011a) An alternative pathway for alphavirus entry. Virol J 8:304. doi:10.1186/1743-422X-8-304
Kononchik JP, Vancini R, Brown DT (2011b) Alphavirus adsorption to mosquito cells as viewed by freeze fracture immunolabeling. Virology 415(2):132–140. doi:10.1016/j.virol.2011.04.011
Krejbich-Trotot P, Denizot M, Hoarau JJ, Jaffar-Bandjee MC, Das T, Gasque P (2011) Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses. FASEB J 25(1):314–325. doi:10.1096/fj.10-164178
La Linn M, Eble JA, Lubken C, Slade RW, Heino J, Davies J, Suhrbier A (2005) An arthritogenic alphavirus uses the alpha1beta1 integrin collagen receptor. Virology 336(2):229–239. doi:10.1016/j.virol.2005.03.015
Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, de Lamballerie X, Suhrbier A, Cherel Y, Le Grand R, Roques P (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120(3):894–906. doi:10.1172/JCI40104
Lam S, Chen KC, Ng MM, Chu JJ (2012) Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced chikungunya virus replication. PLoS One 7(10), e46396. doi:10.1371/journal.pone.0046396
Lee RC, Hapuarachchi HC, Chen KC, Hussain KM, Chen H, Low SL, Ng LC, Lin R, Ng MM, Chu JJ (2013) Mosquito cellular factors and functions in mediating the infectious entry of chikungunya virus. PLoS Negl Trop Dis 7(2), e2050. doi:10.1371/journal.pntd.0002050
Li YG, Siripanyaphinyo U, Tumkosit U, Noranate N, An A, Tao R, Kurosu T, Ikuta K, Takeda N, Anantapreecha S (2013) Chikungunya virus induces a more moderate cytopathic effect in mosquito cells than in mammalian cells. Intervirology 56(1):6–12. doi:10.1159/000339985
Liu CY, Kielian M (2009) E1 mutants identify a critical region in the trimer interface of the Semliki Forest virus fusion protein. J Virol 83(21):11298–11306. doi:10.1128/JVI.01147-09
Lu YE, Cassese T, Kielian M (1999) The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virol 73(5):4272–4278
Maassen JA, Terhorst C (1981) Identification of a cell-surface protein involved in the binding site of Sindbis virus on human lymphoblastic cell lines using a heterobifunctional cross-linker. Eur J Biochem 115(1):153–158
Malygin AA, Bondarenko EI, Ivanisenko VA, Protopopova EV, Karpova GG, Loktev VB (2009) C-terminal fragment of human laminin-binding protein contains a receptor domain for venezuelan equine encephalitis and tick-borne encephalitis viruses. Biochemistry (Mosc) 74(12):1328–1336
Marsh M, Helenius A (1980) Adsorptive endocytosis of Semliki Forest virus. J Mol Biol 142(3):439–454
Marsh M, Bolzau E, Helenius A (1983) Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell 32(3):931–940
Marsh M, Kielian MC, Helenius A (1984) Semliki Forest virus entry and the endocytic pathway. Biochem Soc Trans 12(6):981–983
Mendoza QP, Stanley J, Griffin DE (1988) Monoclonal antibodies to the E1 and E2 glycoproteins of Sindbis virus: definition of epitopes and efficiency of protection from fatal encephalitis. J Gen Virol 69(Pt 12):3015–3022
Mercer J, Schelhaas M, Helenius A (2010) Virus entry by endocytosis. Annu Rev Biochem 79:803–833. doi:10.1146/annurev-biochem-060208-104626
Moller-Tank S, Maury W (2014) Phosphatidylserine receptors: Enhancers of enveloped virus entry and infection. Virology 468–470:565–580. doi:10.1016/j.virol.2014.09.009
Mourya DT, Ranadive SN, Gokhale MD, Barde PV, Padbidri VS, Banerjee K (1998) Putative chikungunya virus-specific receptor proteins on the midgut brush border membrane of Aedes aegypti mosquito. Indian J Med Res 107:10–14
Nieva JL, Bron R, Corver J, Wilschut J (1994) Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J 13(12):2797–2804
Noret M, Herrero L, Rulli N, Rolph M, Smith PN, Li RW, Roques P, Gras G, Mahalingam S (2012) Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts. J Infect Dis 206(3):455–457. doi:10.1093/infdis/jis368, 457–459
Nuckols JT, McAuley AJ, Huang YJ, Horne KM, Higgs S, Davey RA, Vanlandingham DL (2014) pH-dependent entry of chikungunya virus fusion into mosquito cells. Virol J 11(1):215. doi:10.1186/s12985-014-0215-y
Ooi YS, Stiles KM, Liu CY, Taylor GM, Kielian M (2013) Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry. Plos Pathog 9(12), e1003835. doi:10.1371/journal.ppat.1003835
Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger JC, El Amrani M, Yvin JL, Jaffar MC, Frenkiel MP, Sourisseau M, Schwartz O, Butler-Browne G, Despres P, Gessain A, Ceccaldi PE (2007) Human muscle satellite cells as targets of chikungunya virus infection. PLoS One 2(6), e527
Ozden S, Lucas-Hourani M, Ceccaldi PE, Basak A, Valentine M, Benjannet S, Hamelin J, Jacob Y, Mamchaoui K, Mouly V, Despres P, Gessain A, Butler-Browne G, Chretien M, Tangy F, Vidalain PO, Seidah NG (2008) Inhibition of chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein. J Biol Chem 283(32):21899–21908. doi:10.1074/jbc.M802444200
Padmakumar B, Jayan J, Menon R, Krishnankutty B, Payippallil R, Nisha R (2009) Comparative evaluation of four therapeutic regimes in chikungunya arthritis: a prospective randomized parallel-group study. Indian J Rheumatol 4(3):94–101
Paredes AM, Ferreira D, Horton M, Saad A, Tsuruta H, Johnston R, Klimstra W, Ryman K, Hernandez R, Chiu W, Brown DT (2004) Conformational changes in Sindbis virions resulting from exposure to low pH and interactions with cells suggest that cell penetration may occur at the cell surface in the absence of membrane fusion. Virology 324(2):373–386. doi:10.1016/j.virol.2004.03.046
Phalen T, Kielian M (1991) Cholesterol is required for infection by Semliki Forest virus. J Cell Biol 112(4):615–623
Phuklia W, Kasisith J, Modhiran N, Rodpai E, Thannagith M, Thongsakulprasert T, Smith DR, Ubol S (2013) Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis. Virus Res 177(2):179–188. doi:10.1016/j.virusres.2013.08.011
Pohjala L, Utt A, Varjak M, Lulla A, Merits A, Ahola T, Tammela P (2011) Inhibitors of alphavirus entry and replication identified with a stable chikungunya replicon cell line and virus-based assays. PLoS One 6(12), e28923. doi:10.1371/journal.pone.0028923
Priya R, Dhanwani R, Patro IK, Rao PV, Parida MM (2013) Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of chikungunya virus with and without E1:A226V mutation. Infect Genet Evol 20:396–406. doi:10.1016/j.meegid.2013.09.030
Rathore AP, Ng ML, Vasudevan SG (2013) Differential unfolded protein response during chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2alpha phosphorylation. Virol J 10:36. doi:10.1186/1743-422X-10-36
Rohatgi A, Corbo JC, Monte K, Higgs S, Vanlandingham DL, Kardon G, Lenschow DJ (2014) Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus. J Virol 88(5):2414–2425. doi:10.1128/JVI.02716-13
Rose PP, Hanna SL, Spiridigliozzi A, Wannissorn N, Beiting DP, Ross SR, Hardy RW, Bambina SA, Heise MT, Cherry S (2011) Natural resistance-associated macrophage protein is a cellular receptor for sindbis virus in both insect and mammalian hosts. Cell Host Microbe 10(2):97–104. doi:10.1016/j.chom.2011.06.009
Salvador B, Zhou Y, Michault A, Muench MO, Simmons G (2009) Characterization of chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology 393(1):33–41. doi:10.1016/j.virol.2009.07.013
Sam IC, Loong SK, Michael JC, Chua CL, Wan Sulaiman WY, Vythilingam I, Chan SY, Chiam CW, Yeong YS, AbuBakar S, Chan YF (2012) Genotypic and phenotypic characterization of chikungunya virus of different genotypes from Malaysia. PLoS One 7(11), e50476. doi:10.1371/journal.pone.0050476
Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML (2010) Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med 207(2):429–442. doi:10.1084/Jem.20090851
Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Brehin AC, Cubito N, Despres P, Kunst F, Rey FA, Zeller H, Brisse S (2006) Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 3(7), e263
Selvarajah S, Sexton NR, Kahle KM, Fong RH, Mattia KA, Gardner J, Lu K, Liss NM, Salvador B, Tucker DF, Barnes T, Mabila M, Zhou X, Rossini G, Rucker JB, Sanders DA, Suhrbier A, Sambri V, Michault A, Muench MO, Doranz BJ, Simmons G (2013) A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease. PLoS Negl Trop Dis 7(9), e2423. doi:10.1371/journal.pntd.0002423
Shimizu Y, Yamamoto S, Homma M, Ishida N (1972) Effect of chloroquine on the growth of animal viruses. Arch Gesamte Virusforsch 36(1):93–104
Shirako Y, Strauss JH (1994) Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis. J Virol 68(3):1874–1885
Sieczkarski SB, Whittaker GR (2003) Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4(5):333–343
Sigismund S, Woelk T, Puri C, Maspero E, Tacchetti C, Transidico P, Di Fiore PP, Polo S (2005) Clathrin-independent endocytosis of ubiquitinated cargos. Proc Natl Acad Sci U S A 102(8):2760–2765. doi:10.1073/pnas.0409817102
Simizu B, Yamamoto K, Hashimoto K, Ogata T (1984) Structural proteins of chikungunya virus. J Virol 51(1):254–258
Singh K (1967) Cell cultures derived from larvae of Aedes albopictus (Skuse) and Aedes aegypti (L). Curr Sci 36:506
Smit JM, Bittman R, Wilschut J (1999) Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J Virol 73(10):8476–8484
Smith AL, Tignor GH (1980) Host cell receptors for two strains of Sindbis virus. Arch Virol 66(1):11–26
Solignat M, Gay B, Higgs S, Briant L, Devaux C (2009) Replication cycle of chikungunya: a re-emerging arbovirus. Virology 393(2):183–197. doi:10.1016/j.virol.2009.07.024
Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saib A, Rey FA, Arenzana-Seisdedos F, Despres P, Michault A, Albert ML, Schwartz O (2007) Characterization of reemerging chikungunya virus. PLoS Pathog 3(6), e89. doi:10.1371/journal.ppat.0030089
Stanley J, Cooper SJ, Griffin DE (1986) Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol 58(1):107–115
Steinmann J, Buer J, Pietschmann T, Steinmann E (2013) Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol 168(5):1059–1073. doi:10.1111/bph.12009
Suhrbier A, Jaffar-Bandjee MC, Gasque P (2012) Arthritogenic alphaviruses—an overview. Nat Rev Rheumatol 8(7):420–429. doi:10.1038/nrrheum.2012.64
Suomalainen M, Garoff H (1992) Alphavirus spike-nucleocapsid interaction and network antibodies. J Virol 66(8):5106–5109
Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH, Lulla A, Yeo NK, Koh EG, Chow A, Leo YS, Merits A, Chin KC, Ng LF (2012) Viperin restricts chikungunya virus replication and pathology. J Clin Invest 122(12):4447–4460. doi:10.1172/JCI63120
Thon-Hon VG, Denizot M, Li-Pat-Yuen G, Giry C, Jaffar-Bandjee MC, Gasque P (2012) Deciphering the differential response of two human fibroblast cell lines following chikungunya virus infection. Virol J 9:213. doi:10.1186/1743-422X-9-213
Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S (2007) A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 3(12), e201. doi:10.1371/journal.ppat.0030201
Tsetsarkin KA, McGee CE, Higgs S (2011) Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction. Virol J 8:376. doi:10.1186/1743-422X-8-376
Ubol S, Griffin DE (1991) Identification of a putative alphavirus receptor on mouse neural cells. J Virol 65(12):6913–6921
Umashankar M, Sanchez-San Martin C, Liao M, Reilly B, Guo A, Taylor G, Kielian M (2008) Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J Virol 82(18):9245–9253. doi:10.1128/JVI.00975-08
Vancini R, Wang G, Ferreira D, Hernandez R, Brown DT (2013) Alphavirus genome delivery occurs directly at the plasma membrane in a time- and temperature-dependent process. J Virol 87(8):4352–4359. doi:10.1128/JVI.03412-12
Vavre F, Mavingui P (2011) Endosymbionts of arthropods and nematodes: allies to fight infectious diseases? Med Sci 27(11):953–958. doi:10.1051/medsci/20112711010
Villalain J (2010) Membranotropic effects of arbidol, a broad anti-viral molecule, on phospholipid model membranes. J Phys Chem B 114(25):8544–8554. doi:10.1021/jp102619w
Vonderheit A, Helenius A (2005) Rab7 associates with early endosomes to mediate sorting and transport of Semliki Forest virus to late endosomes. PLoS Biol 3(7), e233. doi:10.1371/journal.pbio.0030233
Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA (2010) Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography. Nature 468(7324):709–712. doi:10.1038/nature09555
Waarts BL, Bittman R, Wilschut J (2002) Sphingolipid and cholesterol dependence of alphavirus membrane fusion. Lack of correlation with lipid raft formation in target liposomes. J Biol Chem 277(41):38141–38147. doi:10.1074/jbc.M206998200
Wang KS, Schmaljohn AL, Kuhn RJ, Strauss JH (1991) Antiidiotypic antibodies as probes for the Sindbis virus receptor. Virology 181(2):694–702
Wang KS, Kuhn RJ, Strauss EG, Ou S, Strauss JH (1992) High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 66(8):4992–5001
Weber C, Sliva K, von Rhein C, Kummerer BM, Schnierle BS (2015) The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. Antivir Res 113:1–3. doi:10.1016/j.antiviral.2014.11.001
White J, Helenius A (1980) pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci U S A 77(6):3273–3277
White A, Berman S, Lowenthal JP (1972) Comparative immunogenicities of chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures. Appl Microbiol 23(5):951–952
White LK, Sali T, Alvarado D, Gatti E, Pierre P, Streblow D, Defilippis VR (2011) Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff. J Virol 85(1):606–620. doi:10.1128/JVI.00767-10
Wikan N, Sakoonwatanyoo P, Ubol S, Yoksan S, Smith DR (2012) Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage. PLoS One 7(1), e31102. doi:10.1371/journal.pone.0031102
Wileman T, Boshans RL, Schlesinger P, Stahl P (1984) Monensin inhibits recycling of macrophage mannose-glycoprotein receptors and ligand delivery to lysosomes. Biochem J 220(3):665–675
Wilschut J, Corver J, Nieva JL, Bron R, Moesby L, Reddy KC, Bittman R (1995) Fusion of Semliki Forest virus with cholesterol-containing liposomes at low pH: a specific requirement for sphingolipids. Mol Membr Biol 12(1):143–149
Wintachai P, Wikan N, Kuadkitkan A, Jaimipuk T, Ubol S, Pulmanausahakul R, Auewarakul P, Kasinrerk W, Weng WY, Panyasrivanit M, Paemanee A, Kittisenachai S, Roytrakul S, Smith DR (2012) Identification of prohibitin as a chikungunya virus receptor protein. J Med Virol 84(11):1757–1770. doi:10.1002/jmv.23403
Yamauchi Y, Helenius A (2013) Virus entry at a glance. J Cell Sci 126(Pt 6):1289–1295. doi:10.1242/jcs.119685
Zhu W, Wang L, Yang Y, Jia J, Fu S, Feng Y, He Y, Li JP, Liang G (2010) Interaction of E2 glycoprotein with heparan sulfate is crucial for cellular infection of Sindbis virus. PLoS One 5(3), e9656. doi:10.1371/journal.pone.0009656
Ziegler SA, Nuckols J, McGee CE, Huang YJ, Vanlandingham DL, Tesh RB, Higgs S (2011) In vivo imaging of chikungunya virus in mice and Aedes mosquitoes using a Renilla luciferase clone. Vector Borne Zoonotic Dis 11(11):1471–1477. doi:10.1089/vbz.2011.0648
Acknowledgments
The work cited herein was funded by the French ANR programs CHIKVENDOM and KERABO. We are grateful to the members of the virus–host interaction group for their contributions. Due to space limitations, recognition and apologies are given in advance to the many colleagues whose original contributions have not been possible to cite in this current review.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chazal, N., Briant, L. (2016). Chikungunya Virus Entry and Replication. In: Okeoma, C. (eds) Chikungunya Virus. Springer, Cham. https://doi.org/10.1007/978-3-319-42958-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-42958-8_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42956-4
Online ISBN: 978-3-319-42958-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)